These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3542548)

  • 1. Fasciola hepatica: action in vitro of triclabendazole on immature and adult stages.
    Bennett JL; Köhler P
    Exp Parasitol; 1987 Feb; 63(1):49-57. PubMed ID: 3542548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica.
    Fetterer RH
    J Vet Pharmacol Ther; 1986 Mar; 9(1):49-54. PubMed ID: 3701915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isothermal microcalorimetry to study the activity of triclabendazole and its metabolites on juvenile and adult Fasciola hepatica.
    Keiser J; Manneck T; Kirchhofer C; Braissant O
    Exp Parasitol; 2013 Mar; 133(3):265-8. PubMed ID: 23206957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
    Toner E; McConvery F; Brennan GP; Meaney M; Fairweather I
    Parasitology; 2009 Apr; 136(5):523-35. PubMed ID: 19272211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium.
    Alvarez LI; Mottier ML; Lanusse CE
    Parasitology; 2004 Jan; 128(Pt 1):73-81. PubMed ID: 15002906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation.
    Mottier L; Moreno L; Alvarez L; Virkel G; Lanusse C
    J Pharm Biomed Anal; 2004 Sep; 35(5):991-9. PubMed ID: 15336346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
    Mottier L; Alvarez L; Fairweather I; Lanusse C
    J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics.
    Mottier L; Alvarez L; Ceballos L; Lanusse C
    Exp Parasitol; 2006 May; 113(1):49-57. PubMed ID: 16430886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
    Stitt AW; Fairweather I
    Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
    Stitt AW; Fairweather I
    Parasitology; 1994 Jun; 108 ( Pt 5)():555-67. PubMed ID: 8052511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitology; 2002 Mar; 124(Pt 3):325-38. PubMed ID: 11922434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2003 Sep; 91(2):117-29. PubMed ID: 12910417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of egg production by triclabendazole-resistant Fasciola hepatica following treatment with a commercial preparation of myrrh (Mirazid).
    Abdelaal MMO; Brennan GP; Hanna REB; Abdel-Aziz A; Fairweather I
    Acta Parasitol; 2017 Jun; 62(2):336-347. PubMed ID: 28426420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
    Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
    Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.